National Bankshares Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 9, 2022 and accepted by EDGAR at Nov 9, 2022, 15:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $1.8m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $5.3m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $3.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $6.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | $16.6m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $1.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $2.77 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | $18.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2022-01-01 to 2022-09-30 | $4.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2022-01-01 to 2022-09-30 | $3.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2022-09-30 | $1.70bn | us-gaap:Assets |
| Total liabilities | At period end2022-09-30 | $1.59bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-09-30 | $112.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-22-026560. Last ingested by Listed: Nov 3, 2026, 16:02 ET. Listed shows no prices and gives no investment advice.